| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 55.3941 | 60 |
| GSM780708 | Untreated after 4 days (C2_1) | 51.3006 | 52 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.7982 | 40 |
| GSM780719 | Untreated after 4 days (C1_2) | 54.8839 | 59 |
| GSM780720 | Untreated after 4 days (C2_2) | 59.6272 | 64 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.4663 | 39 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 59.2567 | 64 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.453 | 39 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 57.7594 | 63 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.9407 | 45 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.0966 | 54 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 53.1575 | 56 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.7405 | 51 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 52.0294 | 54 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 57.576 | 62 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.1399 | 33 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 53.8777 | 58 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.6355 | 47 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.7331 | 48 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.2486 | 49 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.0103 | 22 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 48.7559 | 44 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 58.3862 | 63 |